IL301692A - Controlled release fillers and capsules containing them - Google Patents

Controlled release fillers and capsules containing them

Info

Publication number
IL301692A
IL301692A IL301692A IL30169223A IL301692A IL 301692 A IL301692 A IL 301692A IL 301692 A IL301692 A IL 301692A IL 30169223 A IL30169223 A IL 30169223A IL 301692 A IL301692 A IL 301692A
Authority
IL
Israel
Prior art keywords
capsule
fill composition
controlled release
composition
polyethylene oxide
Prior art date
Application number
IL301692A
Other languages
English (en)
Hebrew (he)
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of IL301692A publication Critical patent/IL301692A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL301692A 2020-10-16 2021-10-14 Controlled release fillers and capsules containing them IL301692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063092679P 2020-10-16 2020-10-16
PCT/US2021/054991 WO2022081848A1 (en) 2020-10-16 2021-10-14 Controlled release fill compositions and capsules containing same

Publications (1)

Publication Number Publication Date
IL301692A true IL301692A (en) 2023-05-01

Family

ID=81209315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL301692A IL301692A (en) 2020-10-16 2021-10-14 Controlled release fillers and capsules containing them

Country Status (13)

Country Link
US (1) US20230372252A1 (cg-RX-API-DMAC7.html)
EP (1) EP4228608A4 (cg-RX-API-DMAC7.html)
JP (1) JP7874626B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230088730A (cg-RX-API-DMAC7.html)
CN (1) CN116367864A (cg-RX-API-DMAC7.html)
AR (1) AR123800A1 (cg-RX-API-DMAC7.html)
AU (2) AU2021360905B2 (cg-RX-API-DMAC7.html)
CA (1) CA3195386A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023005368A2 (cg-RX-API-DMAC7.html)
IL (1) IL301692A (cg-RX-API-DMAC7.html)
MX (1) MX2023004441A (cg-RX-API-DMAC7.html)
TW (1) TW202228655A (cg-RX-API-DMAC7.html)
WO (1) WO2022081848A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240099982A1 (en) * 2022-09-27 2024-03-28 Gaia Herbs Cellulose derivative free capsule for herbal extracts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5406530B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
CA2850853A1 (en) * 2011-10-06 2013-04-11 Grunenthal Gmbh Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
CA2978269A1 (en) * 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Immediate release soluble ibuprofen compositions
WO2016170097A1 (en) * 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
MX2017013634A (es) * 2015-04-24 2018-03-08 Gruenenthal Gmbh Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
US9943513B1 (en) * 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms
WO2020068510A1 (en) * 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms

Also Published As

Publication number Publication date
US20230372252A1 (en) 2023-11-23
JP2023545494A (ja) 2023-10-30
JP7874626B2 (ja) 2026-06-16
AU2021360905A9 (en) 2024-10-10
KR20230088730A (ko) 2023-06-20
EP4228608A1 (en) 2023-08-23
NZ799086A (en) 2026-02-27
CO2023005368A2 (es) 2023-05-19
WO2022081848A1 (en) 2022-04-21
CA3195386A1 (en) 2022-04-21
AR123800A1 (es) 2023-01-11
AU2026201700A1 (en) 2026-03-26
AU2021360905A1 (en) 2023-06-01
EP4228608A4 (en) 2024-10-02
MX2023004441A (es) 2023-05-08
AU2021360905B2 (en) 2026-01-08
CN116367864A (zh) 2023-06-30
TW202228655A (zh) 2022-08-01

Similar Documents

Publication Publication Date Title
US12133922B2 (en) Abuse resistant capsule
AU2026201700A1 (en) Controlled release fill compositions and capsules containing same
US20230390210A1 (en) Modified release softgel capsules
HK40090240A (en) Controlled release fill compositions and capsules containing same
AU2021282479A1 (en) Methods and compositions for self-regulated release of active pharmaceuticals ingredients
HK40049427B (en) Abuse resistant capsule
HK40049427A (en) Abuse resistant capsule
HK40004515A (en) Abuse resistant capsule
HK40004515B (en) Abuse resistant capsule